Phase II study of FOLFOXIRI plus panitumumab (pmab) followed by evaluation for resection, in patients (pts) with metastatic KRAS wild-type colorectal cancer (mCRC) with liver metastases only. Meeting Abstract

Industry Collaboration

cited authors

  • Zakari, Ahmed, Gian, Victor G., Meluch, Anthony Alan, Peyton, James D., Waterhouse, David Michael, Lipman, Andrew J., Boccia, Ralph V., Jones, Suzanne Fields, Bendell, Johanna C.

authors

Publication Date

  • May 20, 2014

webpage

published in

category

volume

  • 32

issue

  • 15

WoS Citations

  • 0

WoS References

  • 0